Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism - a prospective, randomized, controlled study-Reference-Cited by-同舟云学术

Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism - a prospective, randomized, controlled study

Author:

Chen Si-Yang¹,Li Jia-Li²,Meng Fan-Hang³,Wang Xue-Ding²,Liu Tao⁴,Li Jun⁵,Liu Long-Shan⁵,Fu Qian⁵,Huang Min²,Wang Chang-Xi⁶

Affiliation:

1. Anesthesia Department; The First Affiliated Hospital of Sun Yat-sen University; Guangzhou; China

2. Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University; Guangzhou; China

3. Kidney Transplant Department; The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China

4. Department of Biostatistics & Epidemiology; School of Public Health, Sun Yat-sen University; Guangzhou; China

5. Kidney Transplant Department; Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University; Guangzhou; China

6. Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University; Guangzhou; China

Publisher

Wiley

Subject

Transplantation

Reference30 articles.

1. Clinical pharmacokinetics of tacrolimus;Venkataramanan;Clin Pharmacokinet,1995

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献